Kenneth D. Aldape

Molecular Biology · 2003–2019

A researcher in the Science corpus: 29 papers; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Kenneth D. Aldape trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. D. Lockhart

Papers from Kenneth D. Aldape's perspective

Ordered by how strongly the researchers Kenneth D. Aldape trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. (New England Journal of Medicine)
  2. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. (Cancer Cell)
  3. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate (Nature)
  4. Identification of human brain tumour initiating cells (Nature)
  5. An integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR and NF1 (Cancer Cell)
  6. Regularization Paths for Generalized Linear Models via Coordinate Descent
  7. Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases (Cancer Cell)
  8. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays (Bioinform.)
  9. Analysis of the IDH1 codon 132 mutation in brain tumors (Acta Neuropathologica)
  10. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma (Nature)

Their papers